Filtered By:
Condition: Thrombosis

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 15499 results found since Jan 2013.

In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke
Isr Med Assoc J. 2022 Dec 1;25(12):853-854.ABSTRACTEndovascularly retrieved clots may be a potential resource for diagnosing stroke etiology. This method may influence secondary prevention treatment. We measure thrombin activity eluted by serially washing clots. We concluded that an assay measuring the change in thrombin in clots retrieved during acute stroke endovascular thrombectomy procedures may serve as a diagnostic marker of the origin of the clot. The suggested mechanism for these differences may be the clot location before its retrieval, with high blood flow causing thrombin washout in atherosclerotic clots, in con...
Source: The Israel Medical Association Journal - August 16, 2023 Category: General Medicine Authors: Ze'ev Itsekson Hayosh Eiman Abu Bandora Natalia Shelestovich Maya Nulman Mati Bakon Gal Yaniv Boris Khaitovitch Shmuel Balan Alexandra Gerasimova Tali Drori Stefan Mausbach Yvonne Schwammenthal Arnon Afek Joab Chapman Efrat Shavit Stein David Orion Source Type: research

Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study
ConclusionICI-treated patients may exhibit a higher risk of ATEs, especially after 1  year of treatment.
Source: Cancer Medicine - August 16, 2023 Category: Cancer & Oncology Authors: Jie Zhu, Yue Chen, Yuanlong Zhang, Wei Wang, Yujue Wang, Zhuo Lu, Yulin Zhang, Haike Lei, Dairong Li, Bo Long, Haixia Liu Tags: RESEARCH ARTICLE Source Type: research

The potential link between acromegaly and risk of acute ischemic stroke in patients with pituitary adenoma: a new perspective
AbstractAcromegaly is an endocrine disorder due to the excess production of growth hormone (GH) from the anterior pituitary gland after closed epiphyseal growth plates. Acromegaly is mainly caused by benign GH-secreting pituitary adenoma. Acute ischemic stroke (AIS) is one of the most common cardiovascular complications. It ranks second after ischemic heart disease (IHD) as a cause of disability and death in high-income countries globally. Thus, this review aimed to elucidate the possible link between acromegaly and the development of AIS. The local effects of acromegaly in the development of AIS are related to the develop...
Source: Acta Neurologica Belgica - August 16, 2023 Category: Neurology Source Type: research

Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences
AbstractPurpose of ReviewLeft atrial appendage closure (LAAC) has shown to be non-inferior to oral anticoagulation (OAC) for non-valvular atrial fibrillation (AF). LAAC is now becoming a leading method for stroke prophylaxis in patients who have atrial fibrillation and are unable to tolerate OAC. There are currently two FDA-approved endocardial closure devices, namely, the Watchman FLX and Amplatzer Amulet.Recent FindingsCurrent data highlights that both devices offer similar efficacy and safety for LAAC. While the two devices differ in terms of intraprocedural complication rates, they offer similar short- to long-term out...
Source: Current Cardiology Reports - August 16, 2023 Category: Cardiology Source Type: research

The potential link between acromegaly and risk of acute ischemic stroke in patients with pituitary adenoma: a new perspective
AbstractAcromegaly is an endocrine disorder due to the excess production of growth hormone (GH) from the anterior pituitary gland after closed epiphyseal growth plates. Acromegaly is mainly caused by benign GH-secreting pituitary adenoma. Acute ischemic stroke (AIS) is one of the most common cardiovascular complications. It ranks second after ischemic heart disease (IHD) as a cause of disability and death in high-income countries globally. Thus, this review aimed to elucidate the possible link between acromegaly and the development of AIS. The local effects of acromegaly in the development of AIS are related to the develop...
Source: Acta Neurologica Belgica - August 16, 2023 Category: Neurology Source Type: research

Metabolite signature in acute ischemic stroke thrombi: a systematic review
In conclusion, results of the present study show that the thrombi niche has a glycolytic phenotype. Future studies should work to better understand the metabolic properties of AIS thrombi.
Source: Journal of Thrombosis and Thrombolysis - August 14, 2023 Category: Hematology Source Type: research

Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study
CONCLUSIONS: In patients with stable CAD treated with pitavastatin and who achieved guidelines-directed levels of LDL-C, eGFR and HbA1c were independently associated with adverse events, suggesting that renal function and glycemic control could be residual non-lipid therapeutic targets after statin therapy.PMID:37574272 | DOI:10.5551/jat.64304
Source: Journal of Atherosclerosis and Thrombosis - August 13, 2023 Category: Cardiology Authors: Kiwamu Kamiya Makoto Takei Toshiyuki Nagai Toru Miyoshi Hiroshi Ito Yoshihiro Fukumoto Hitoshi Obara Tatsuyuki Kakuma Ichiro Sakuma Hiroyuki Daida Satoshi Iimuro Hiroaki Shimokawa Takeshi Kimura Ryozo Nagai Toshihisa Anzai REAL-CAD study investigators Source Type: research

Predictive Model for PICC Occlusion Risk for Patients in Intensive Care Units: A Retrospective Clinical Study
CONCLUSIONS: Age ≥65 years, BMI ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for PICC occlusion, while the frequency of flushing and sealing pipe (Q8h) was a protective factor. This prediction model had an outstanding ability to discriminate in identifying patients with a high-risk of PICC occlusion in the ICU.PMID:37573601
Source: Alternative Therapies in Health and Medicine - August 13, 2023 Category: Complementary Medicine Authors: Yijun Zhu Diwen Li Yunfei Li Weiwei Cai Source Type: research

Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study
CONCLUSIONS: In patients with stable CAD treated with pitavastatin and who achieved guidelines-directed levels of LDL-C, eGFR and HbA1c were independently associated with adverse events, suggesting that renal function and glycemic control could be residual non-lipid therapeutic targets after statin therapy.PMID:37574272 | DOI:10.5551/jat.64304
Source: Journal of Atherosclerosis and Thrombosis - August 13, 2023 Category: Cardiology Authors: Kiwamu Kamiya Makoto Takei Toshiyuki Nagai Toru Miyoshi Hiroshi Ito Yoshihiro Fukumoto Hitoshi Obara Tatsuyuki Kakuma Ichiro Sakuma Hiroyuki Daida Satoshi Iimuro Hiroaki Shimokawa Takeshi Kimura Ryozo Nagai Toshihisa Anzai REAL-CAD study investigators Source Type: research

Predictive Model for PICC Occlusion Risk for Patients in Intensive Care Units: A Retrospective Clinical Study
CONCLUSIONS: Age ≥65 years, BMI ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for PICC occlusion, while the frequency of flushing and sealing pipe (Q8h) was a protective factor. This prediction model had an outstanding ability to discriminate in identifying patients with a high-risk of PICC occlusion in the ICU.PMID:37573601
Source: Alternative Therapies in Health and Medicine - August 13, 2023 Category: Complementary Medicine Authors: Yijun Zhu Diwen Li Yunfei Li Weiwei Cai Source Type: research

Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study
CONCLUSIONS: In patients with stable CAD treated with pitavastatin and who achieved guidelines-directed levels of LDL-C, eGFR and HbA1c were independently associated with adverse events, suggesting that renal function and glycemic control could be residual non-lipid therapeutic targets after statin therapy.PMID:37574272 | DOI:10.5551/jat.64304
Source: Journal of Atherosclerosis and Thrombosis - August 13, 2023 Category: Cardiology Authors: Kiwamu Kamiya Makoto Takei Toshiyuki Nagai Toru Miyoshi Hiroshi Ito Yoshihiro Fukumoto Hitoshi Obara Tatsuyuki Kakuma Ichiro Sakuma Hiroyuki Daida Satoshi Iimuro Hiroaki Shimokawa Takeshi Kimura Ryozo Nagai Toshihisa Anzai REAL-CAD study investigators Source Type: research